K L Bourantas
Overview
Explore the profile of K L Bourantas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
270
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benetatos L, Alymara V, Vassou A, Bourantas K
Int J Lab Hematol
. 2008 Mar;
30(2):167-72.
PMID: 18333849
Thalassemia represents the world's most common monogenic disease, characterized by absence of or decreased globin chain production. The lifespan of thalassemia patients has been extended as a result of current...
2.
Benetatos L, Dasoula A, Syed N, Hatzimichael E, Crook T, Bourantas K
Leukemia
. 2007 Dec;
22(6):1293-5.
PMID: 18094722
No abstract available.
3.
Tsiara S, Chaidos A, Bourantas L, Kapsali H, Bourantas K
Acta Haematol
. 2006 Dec;
117(3):156-61.
PMID: 17159338
Background: Patients with chronic idiopathic myelofibrosis (CIMF) usually present with anaemia. Treatment is often palliative and the majority of patients receive regular red blood cell (RBC) transfusions. Although recombinant human...
4.
Hatzimichael E, Benetatos L, Stebbing J, Kapsali E, Panayiotopoulou S, Bourantas K
Clin Lab Haematol
. 2006 Nov;
28(6):416-8.
PMID: 17105496
Growth factors are a significant advance in the supportive care of patients with cancer with a wide range of indications. Frequent side effects of G-CSF include bone pain, headache, fatigue...
5.
Benetatos L, Vassou A, Bourantas K
Clin Lab Haematol
. 2006 Aug;
28(4):288-9.
PMID: 16898975
No abstract available.
6.
Vassou A, Alymara V, Chaidos A, Bourantas K
Int J Hematol
. 2005 Sep;
81(5):421-3.
PMID: 16158824
Cold agglutinin disease (CAD) is an uncommon autoimmune hemolytic anemia characterized by B-cell proliferation. Conventional therapies for primary CAD such as corticosteroids, oral alkylating agents, splenectomy, interferon alpha, and plasma...
7.
Panteli K, Zagorianakou N, Agnantis N, Bourantas K, Bai M
Acta Haematol
. 2005 Aug;
114(2):99-103.
PMID: 16103633
The aim of this study was to investigate the prognostic relevance of angiogenesis expressed as bone marrow microvessel density (MVD) in 40 patients with essential thrombocythemia (ET). Bone marrow MVD...
8.
Voulgari P, Karali A, Alymara V, Chaidos A, Bourantas K, Drosos A
Clin Exp Rheumatol
. 2005 May;
23(2):278.
PMID: 15895910
No abstract available.
9.
Alymara V, Tzouvara E, Vartholomatos G, Chaidos A, Tsiara S, Bourantas K
J Exp Clin Cancer Res
. 2004 Dec;
23(3):447-54.
PMID: 15595635
Acute myeloid leukemia (AML) predominantly affects older adults, a population with a poor prognosis, due to age, comorbidities and forms of disease. We present a retrospective study of 45 patients...
10.
Tsabouri S, Georgiou I, Katsaraki A, Bourantas K
J Exp Clin Cancer Res
. 2004 Dec;
23(3):417-24.
PMID: 15595630
Glutathione S-transferases (GSTs) are a group of enzymes involved in the detoxification process of carcinogens and other substances. The genes encoding isoenzymes M1 and T1 have "null" alleles, which are...